High-calorie diet with moderate protein restriction prevents cachexia and ameliorates oxidative stress, inflammation and proteinuria in experimental chronic kidney disease

Clinical and Experimental Nephrology

Volumn 14, Issue 6, 2010, Pages 536-547

  Kim, Hyun Ju ^a   Vaziri, Nosratola D ^a   Norris, Keith ^b   An, Won Suk ^a   Quiroz, Yasmir ^c   Rodriguez Iturbe, Bernardo ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^c UNIVERSIDAD DEL ZULIA   (Venezuela)

Author keywords

Chronic renal disease progression; Dyslipidemia; High calorie diet; Inflammation; Malnutrition; Uremic cachexia

Indexed keywords

ADIPONECTIN; CASPASE 3; CONNECTIVE TISSUE GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; LEPTIN; LIPOXYGENASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN BAX; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TRANSFORMING GROWTH FACTOR BETA; TRIACYLGLYCEROL; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CACHEXIA; CARBOHYDRATE INTAKE; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; FAT INTAKE; FATTY ACID BLOOD LEVEL; GLOMERULOSCLEROSIS; HYPERTENSION; INFLAMMATION; INTERSTITIAL NEPHRITIS; LIPID DIET; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN INTAKE; PROTEIN RESTRICTION; PROTEINURIA; RAT; UPREGULATION; UREMIA; WEIGHT GAIN; WEIGHT REDUCTION;

ADIPONECTIN; ANIMALS; BCL-2-ASSOCIATED X PROTEIN; CACHEXIA; CASPASE 3; CREATININE; DIET, PROTEIN-RESTRICTED; DIETARY FATS; ENERGY INTAKE; INFLAMMATION; LEPTIN; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; PROTEINURIA; RATS; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 78650944311     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-010-0340-x     Document Type: Article

References (45)

1. P Degoulet M Legrain I Réach F Aimé C Devriés P Rojas, et al. 1982 Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative study Nephron 31 103 110 1:STN:280:DyaL3s%2FhtlWjtg%3D%3D 10.1159/000182627 7121651
2. SD Leavy RL Strawderman CA Jones FK Port PJ Held 1998 Simple nutritional indicators as independent predictors of mortality in hemodialysis patients Am J Kidney Dis 31 997 1006 10.1053/ajkd.1998.v31.pm9631845
3. JD Kopple X Zhu NL Lew EG Lowrie 1999 Body weight-for-height relationships predict mortality in hemodialysis patients Kidney Int 56 1136 1148 1:STN:280:DyaK1MzpvVGntw%3D%3D 10.1046/j.1523-1755.1999.00615.x 10469384 (Pubitemid 29411743)
4. E Fleishmann N Teal J Dudley W May JD Bower AK Salahudeen 1999 Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients Kidney Int 55 1560 1567 10.1046/j.1523-1755.1999.00389.x (Pubitemid 29157157)
5. SF Leavy K McCullough E Hecking D Goodkin FK Port EW Young 2001 Body mass index and mortality in "healthier" as compared with "sicker" hemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS) Nephrol Dial Transplant 16 2386 2394 10.1093/ndt/16.12.2386
6. CW Glanton IO Hypolite PB Hshieh LY Agoada CM Yuan KC Abott 2003 Factors associated with short term survival in obese end stage renal disease patients Ann Epidemiol 13 136 143 10.1016/S1047-2797(02)00251-X 12559673 (Pubitemid 36143713)
7. K Kalantar-Zadeh CJ McAllister RS Lehn GH Lee AR Nissenson JD Kopple 2003 Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients Am J Kidney Dis 42 761 773 10.1016/S0272-6386(03)00915-6 14520627 (Pubitemid 37187377)
8. KC Abbott CW Glanton FC Trespalacios DK Oliver MI Ortiz LY Agodoa, et al. 2004 Body mass index, dialysis modality and survival: analysis of the United States Data System Dialysis Morbidity and Mortality Wave II Study Kidney Int 65 597 605 10.1111/j.1523-1755.2004.00385.x 14717930 (Pubitemid 38130654)
9. RN Foley PS Parfrey MJ Sarnak 1998 Epidemiology of cardiovascular disease in chronic renal disease J Am Soc Nephrol 9 S16 S23 1:STN:280: DC%2BD3MzovF2lug%3D%3D 11443763
10. PG Zager J Nikolic RH Brown MA Campbell WC Hunt D Peterson, et al. 1998 "U" curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc Kidney Int 54 561 569 1:STN:280:DyaK1czlsVKrsw%3D%3D 10.1046/j.1523-1755.1998.00005.x 9690224 (Pubitemid 28357420)
11. Y Nishizawa T Shoji E Ishimura M Inaba H Morii 2001 Paradox of risk factors for cardiovascular mortality in uremia: is a higher cholesterol level better for atherosclerosis in uremia? Am J Kidney Dis 38 S4 S7 1:STN:280:DC%2BD3MrjtVSisQ%3D%3D 10.1053/ajkd.2001.27380 11576913
12. K Kalantar-Zadeh G Block MH Humphreys CJ McAllister JD Kopple 2004 A low, rather than a high, total plasma homocysteine is an indicator of poor outcome in hemodialysis patients J Am Soc Nephrol 15 442 452 1:CAS:528: DC%2BD2cXkt1ykuw%3D%3D 10.1097/01.ASN.0000107564.60018.51 14747392 (Pubitemid 38140786)
13. EJ Lowrie NL Lew 1990 Death risk in hemodialysis patients: the predictive value of commonly measured variables and an elevation of death rate differences between facilities Am J Kidney Dis 15 458 482 1:STN:280:DyaK3c3ktVaitg%3D%3D 2333868
14. K Kalantar-Zadeh G Block MH Humphreys JD Kopple 2003 Reverse epidemiology of cardiovascular disease risk factors in maintenance dialysis Kidney Int 63 793 808 10.1046/j.1523-1755.2003.00803.x 12631061 (Pubitemid 36315558)
15. B Rodriguez-Iturbe Y Quiroz A Shahkarami Z Li ND Vaziri 2005 Mycophenolate mofetil ameliorates nephropathy in the obese Zucker rat Kidney Int 68 1041 1047 1:CAS:528:DC%2BD2MXhtVCjt7zI 10.1111/j.1523-1755.2005.00496.x 16105034 (Pubitemid 43246420)
16. S Reddy N Santanam PP Reddy JA Rock AA Murphy S Parthasarathy 1997 Interaction of interceed oxidized regenerated cellulose with macrophages: a potential mechanism by which interceed may prevent adhesions Am J Obstet Gynecol 177 1315 1320 1:CAS:528:DyaK1cXltVClug%3D%3D 10.1016/S0002-9378(97)70070-X 9423730 (Pubitemid 28040222)
17. AR Chade OP Mushin X Zhu M Rodriguez-Porcel JP Grande SC Textor, et al. 2005 Pathways of renal fibrosis and modulation of matrix turnover in experimental hypercholesterolemia Hypertension 46 772 779 1:CAS:528: DC%2BD2MXhtV2htrzN 10.1161/01.HYP.0000184250.37607.da 16172424 (Pubitemid 43186752)
18. XZ Ruan Z Varghese SH Powis JF Moorhead 1999 Human mesangial cells express inducible macrophage scavenger receptor Kidney Int 56 440 451 1:CAS:528:DyaK1MXltlOhurc%3D 10.1046/j.1523-1755.1999.00587.x 10432382 (Pubitemid 29353141)
19. DM Okamura JM Lopez-Guisa K Koelsch S Collins AA Eddy 2007 Atherogenic scavenger receptor modulation in the tubulointerstitium in response to chronic renal injury Am J Physiol Renal Physiol 293 F575 F585 1:CAS:528: DC%2BD2sXptlyqu70%3D 10.1152/ajprenal.00063.2007 17537985 (Pubitemid 47358129)
20. Kim H-J, Yuan J, Norris K, Vaziri ND. High calorie diet partially ameliorates dysregulation of intra-renal lipid metabolism in the remnant kidney. J Nutr Biochem. 2009. doi: 10.1016/j.jnutbio.2009.08.006.
21. HJ Kim ND Vaziri 2010 Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure Am J Physiol Renal Physiol 298 F662 F671 1:CAS:528:DC%2BC3cXjsFGnuro%3D 10.1152/ajprenal.00421.2009 20007347
22. V Alvarez Y Quiroz M Nava H Pons B Rodriguez-Iturbe 2002 Overload proteinuria is followed by salt-sensitive hypertension caused by renal infiltration of immune cells Am J Physiol Renal Physiol 283 F1132 F1141 12372790
23. B Rodriguez-Iturbe A Ferrebuz V Vanegas Y Quiroz S Mezzano ND Vaziri 2005 Early and sustained inhibition of Nuclear Factor kappa B prevents hypertension in spontaneously hypertensive rats J Pharmacol Exp Ther 315 51 57 1:CAS:528:DC%2BD2MXhtVOksrfO 10.1124/jpet.105.088062 15951402 (Pubitemid 41380497)
24. Y Quiroz A Ferrebuz F Romero ND Vaziri B Rodriguez-Iturbe 2008 Melatonin ameliorates oxidative stress, inflammation, proteinuria and progression of renal damage in rats with renal mass reduction Am J Physiol Renal Physiol 294 F336 F344 1:CAS:528:DC%2BD1cXit1yks7w%3D 10.1152/ajprenal.00500.2007 18077597 (Pubitemid 351199398)
25. K-H Cho H-J Kim B Rodriguez-Iturbe ND Vaziri 2009 Niacin ameliorates oxidative stress, inflammation, proteinuria, and hypertension in rats with chronic renal failure Am J Physiol Renal Physiol 297 F106 F113 1:CAS:528:DC%2BD1MXovVKhs7Y%3D 10.1152/ajprenal.00126.2009 19420110
26. Y Quiroz A Ferrebuz ND Vaziri B Rodriguez-Iturbe 2009 Effect of chronic antioxidant therapy with superoxide dismutase-mimetic drug, tempol, on progression of renal disease in rats with renal mass reduction Nephron Exp Nephrol 112 e31 e42 1:CAS:528:DC%2BD1MXmtFequ7w%3D 10.1159/000210577 19342872
27. D Fouque M Aparicio 2007 Eleven reasons to control the protein intake of patients with chronic kidney disease Nat Clin Pract Nephrol 3 383 392 1:CAS:528:DC%2BD2sXosFaqs7w%3D 10.1038/ncpneph0524 17592471 (Pubitemid 46987805)
28. ND Vaziri 2003 Molecular mechanisms of lipid dysregulation in nephrotic syndrome Kidney Int 63 1964 1976 10.1046/j.1523-1755.2003.00941.x 12675893 (Pubitemid 36513360)
29. C Zoccali F Mallamaci G Tripepi FA Benedetto S Cutrupi S Parlongo, et al. 2002 Adiponectin, metabolic risk factors, and cardiovascular events among patients with endstage renal disease J Am Soc Nephrol 13 134 141 1:CAS:528:DC%2BD38XltV2gsQ%3D%3D 10.1097/01.ASN.0000032548.18973.0F 11752030
30. C Zoccali F Mallamaci 2007 Adiponectin and renal disease progression: another epidemiologic conundrum Kidney Int 71 1195 1197 1:CAS:528: DC%2BD2sXmtFeqsbg%3D 10.1038/sj.ki.5002319 17554349 (Pubitemid 46887542)
31. R Pecoits-Filho B Lindholm P Stenvinkel 2002 The malnutrition, inflammation, and atherosclerosis (MIA) syndrome - the heart of the matter Nephrol Dial Transplant 17 Suppl 11 28 31 1:CAS:528:DC%2BD38Xptlektrg%3D 12386254
32. JJ Díez P Iglesias MJ Fernández-Reyes A Aguilera MA Bajo P Alvarez-Fidalgo, et al. 2005 Serum concentrations of leptin, adiponectin and resistin, and their relationship with cardiovascular disease in patients with end-stage renal disease Clin Endocrinol 62 242 249 10.1111/j.1365-2265.2005. 02207.x (Pubitemid 40203922)
33. T Kadowaki T Yamauchi 2005 Adiponectin and adiponectin receptor Endocr Rev 26 439 445 1:CAS:528:DC%2BD2MXltVWru7c%3D 10.1210/er.2005-0005 15897298 (Pubitemid 40686653)
34. KL Johansen K Mulligan V Tai M Schambelan 1998 Leptin, body composition and indices of malnutrition in patients in dialysis J Amer Soc Nephrol 9 1080 1084 1:CAS:528:DyaK1cXjvFWisLk%3D
35. MA Aminzadeh MV Pahl CH Barton ND Vaziri 2009 Human uremic plasma stimulates release of leptin and uptake of tumor necrosis factor-α in visceral adipocytes Nephrol Dial Transplant 24 3626 3631 1:CAS:528: DC%2BD1MXhsVyqsbbI 10.1093/ndt/gfp405 19666662
36. S-C Hung T-Y Tung C-S Yang D-C Tarng 2005 High-calorie supplementation increases serum leptin levels and improves response to rHuEPO in long-term hemodialysis patients Am J Kidney Dis 45 1073 1083 1:CAS:528: DC%2BD2MXlvVSjs7g%3D 10.1053/j.ajkd.2005.02.020 15957137 (Pubitemid 40806521)
37. A Takeda T Toda S Shinohara Y Mogi N Matsui 2002 Factors contributing to higher hematocrit levels in hemodialysis patients not receiving recombinant human erythropoietin Am J Kidney Dis 40 104 109 1:CAS:528:DC%2BD38Xlsl2itLk%3D 10.1053/ajkd.2002.33918 12087567 (Pubitemid 34701217)
38. I Sinuani J Weissgarten I Beberashvili MJ Rapoport J Sandbank L Feldman, et al. 2009 The cyclin kinase inhibitor p57kip2 regulates TGF-β-induced compensatory tubular hypertrophy: effect of the immunomodulator AS101 Nephrol Dial Transplant 24 2328 2338 1:CAS:528:DC%2BD1MXptVamtbg%3D 10.1093/ndt/gfn742 19321762
39. M Chen S Narumiya T Masaki T Sawamura 2001 Conserved C-terminal residues within the lectin-like domain of LOX-1 are essential for oxidized low-density-lipoprotein binding Biochem J 355 289 296 1:CAS:528: DC%2BD3MXjsValur4%3D 10.1042/0264-6021:3550289 11284714 (Pubitemid 32397786)
40. S Mita N Kobayashi K Yoshida S Nakano H Matsuoka 2005 Cardioprotective mechanisms of Rho-kinase inhibition associated with NOS and oxidative stress-LOX-1 pathway in Dahl salt-sensitive hypertensive rats J Hypertens 23 87 96 1:CAS:528:DC%2BD2MXitVCitA%3D%3D 10.1097/00004872-200501000-00017 15643129 (Pubitemid 40128985)
41. JL Metha J Chen PL Hermonat F Romeo G Novelli 2006 Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders Cardiovasc Res 69 36 45 10.1016/j.cardiores.2005.09.006 (Pubitemid 41814809)
42. HJ Kim H Moradi J Yuan K Norris ND Vaziri 2009 Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney Am J Physiol Renal Physiol 296 F1297 F1306 1:CAS:528:DC%2BD1MXnsF2ksrk%3D 10.1152/ajprenal.90761.2008 19357177
43. Z Tumur H Shimizu A Enomoto H Miyazaki T Niwa 2010 Indoxyl sulfate upregulates expression of ICAM-1 and MCP-1 by oxidative stress-induced NF-kappaB activation Am J Nephrol 31 435 441 1:CAS:528:DC%2BC3cXlvVGju70%3D 10.1159/000299798 20389059
44. Sinha-Hikim I, Shen R, Paul Lee WN, Crum A, Vaziri ND, Norris KC. Effects of a novel cystine based glutathione precursor on oxidative stress in vascular smooth muscle cells. Am J Physiol Cell Physiol. 2010. doi: 10.1152/ajpcell. 00434.2009.
45. K Igarashi S Ueda K Yoshida K Kashiwagi 2006 Polyamines in renal failure Amino Acids 31 477 483 1:CAS:528:DC%2BD28Xht1GmsrzN 10.1007/s00726-006-0264-7 16554974 (Pubitemid 44853470)